HYPERION DEFI, INC. Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
HYPERION DEFI, INC. (HYPD) reported Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) of $768.86 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill · last filed 2026-08-13
- HYPERION DEFI, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2026-06-30 was $768.86K.
- HYPERION DEFI, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2026-03-31 was $1.23M.
- HYPERION DEFI, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2025-12-31 was $20.90M.
- HYPERION DEFI, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2025-09-30 was $6.29M.
- HYPERION DEFI, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2025 was $27.19M.
| Period end | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 3 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 6 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 9 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $768.86K 10-Q · filed 2026-08-13 | $2.00M 10-Q · filed 2026-08-13 | $22.90M derived: sum of 3 quarters · filed 2026-08-13 | $29.19M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $1.23M 10-Q · filed 2026-05-15 | $22.13M derived: sum of 2 quarters · filed 2026-05-15 | $28.42M derived: sum of 3 quarters · filed 2026-05-15 | |
| 2025-12-31 | $20.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $27.19M derived: sum of 2 quarters · filed 2026-03-30 | $27.19M 10-K · filed 2026-03-30 | |
| 2025-09-30 | $6.29M 10-Q · filed 2025-11-14 | $6.29M 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |